中国循证医学杂志

中国循证医学杂志

2017年ESC/EACTs 与 AHA/ACC 心脏瓣膜疾病管理的指南解读

查看全文

关键词: 心脏瓣膜病; 经导管主动脉瓣置换术; 指南; 指南解读

Key words: Valvular heart disease; TAVI; Guideline; Guideline interpretation

引用本文: 欧袁伟翔, 李怡坚, 陈茂. 2017年ESC/EACTs 与 AHA/ACC 心脏瓣膜疾病管理的指南解读. 中国循证医学杂志, 2017, 17(11): 1260-1264. doi: 10.7507/1672-2531.201710001 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med, 2016, 374(17): 1609-1620.
2. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet, 2016, 387(10034): 2218-2225.
3. John B, Chambers BP, Bernard I, et al. Standards defining a ‘Heart Valve Centre’: ESC Working Group on valvular heart disease and European Association for cardiothoracic surgery viewpoint. Eur J Cardiothorac Surg, 2017, 52(3): 418-424.
4. Barili F, Pacini D, Capo A, et al. Does EuroSCORE Ⅱ perform better than its original versions? A multicentre validation study. Eur Heart J, 2013, 34(1): 22-29.
5. Osnabrugge RL, Speir AM, Head SJ, et al. Performance of EuroSCORE Ⅱ in a large US database: implications for transcatheter aortic valve implantation. Eur J Cardiothorac Surg, 2014, 46(3): 400-408.
6. Puri R, Iung B, Cohen DJ, et al. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J, 2016, 37(28): 2217-2225.
7. Edwards FH, Cohen DJ, O'Brien SM, et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol, 2016, 1(1): 46-52.
8. Iung B, Laouenan C, Himbert D, et al. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart, 2014, 100(13): 1016-1023.
9. Tribouilloy C, Rusinaru D, Marechaux S, et al. Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery. J Am Coll Cardiol, 2015, 65(1): 55-66.
10. Deeb GM, Reardon MJ, Chetcuti S, et al. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol, 2016, 67(22): 2565-2574.
11. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363(17): 1597-1607.
12. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med, 2017, 376(14): 1321-1331.
13. Siontis GC, Praz F, Pilgrim T, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J, 2016, 37(47): 3503-3512.
14. Zhao ZG, Jilaihawi H, Feng Y, et al. Transcatheter aortic valve implantation in bicuspid anatomy. Nat Rev Cardiol, 2015, 12(2): 123-128.
15. Chiang YP, Chikwe J, Moskowitz AJ, et al. Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA, 2014, 312(13): 1323-1329.
16. Chikwe J, Chiang YP, Egorova NN, et al. Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years. JAMA, 2015, 313(14): 1435-1442.
17. Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol, 2016, 68(19): 2059-2069.
18. Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med, 2015, 373(21): 2015-2024.
19. Pache G, Schoechlin S, Blanke P, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J, 2016, 37(28): 2263-2271.
20. Pislaru SV, Hussain I, Pellikka PA, et al. Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series. Eur J Cardiothorac Surg, 2015, 47(4): 725-732.
21. Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170.
22. Phan K, Zhao DF, Wang N, et al. Transcatheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review. J Thorac Dis, 2016, 8(1): 83-93.
23. Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST Ⅱ (endovascular valve edge-to-edge repair) high risk study. J Am Coll Cardiol, 2012, 59(2): 130-139.